Drug approval in Australia can take anywhere from 12 to 24 months, but timeframes can be shorter if theres a strong public interest in expediting the review process
IGF-1 LR3 can benefit anyone looking to improve muscle growth, speed up recovery, or boost overall wellness

[17] [18] Evidence-based strategies to optimise long-term effectiveness include: Regular dose review : Working with healthcare providers to ensure patients are on an appropriate therapeutic dose, with consideration for dose escalation if weight loss plateaus and the medication is well-tolerated Structured lifestyle support : Engaging with dietitians, physiotherapists, or NHS weight management programmes to reinforce behavioural changes and prevent gradual increases in caloric intake Monitoring and accountability : Regular follow-up appointments to track weight, metabolic parameters, and treatment adherence, as recommended in NICE guidelines for obesity management Addressing side effects proactively : Managing gastrointestinal symptoms or other adverse effects to improve adherence and prevent treatment discontinuation It's important to note that current evidence and clinical guidelines do not support the use of "medication holidays" or cycling of GLP-1 treatments

You can ask your GP or practice nurse to refer you to an NHS Tier 2 or Tier 3 weight management service, depending on your clinical needs and local availability
Physicians begin low and then gradually increase to reduce the risk of gastric side effects, including nausea and vomiting